Monthly Injectable BUP for MA Use Disorder (MURB) Trial
Status:
Not yet recruiting
Trial end date:
2024-04-01
Target enrollment:
Participant gender:
Summary
This study is a 12-week randomized, double-blind, placebo-controlled trial that will
investigate the use of injectable buprenorphine (BUP-Inj) compared to injectable placebo
(PBO-Inj) for the treatment of methamphetamine use disorder (MUD) among individuals with mild
co-use of opioids.